Results 171 to 180 of about 15,981,489 (330)

Cumulative incidence of perianal manifestations in pediatric‐onset inflammatory bowel disease: A nationwide Swedish cohort study

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Perianal disease is a recognized complication of pediatric Crohn's disease (CD), but data on ulcerative colitis (UC) and inflammatory bowel disease unclassified (IBD‐U) are limited. We examined the occurrence of perianal disease before, at, and after diagnosis of pediatric‐onset IBD compared with matched (age, sex, and geographical region ...
Åsa H. Everhov, Jonas Söderling, Caroline Nordenvall, The SWIBREG Study Group, Jonas F. Ludvigsson, Pär Myrelid, Ola Olén, Martin Rejler, Ulrika Fagerberg, Charlotte Hedin, Hans Strid, Karl Mårild   +11 more
wiley   +1 more source

Mast cell-derived IL-13 as a driver of Crohn disease-associated intestinal fibrosis. [PDF]

Inflamm Bowel Dis
Safari K, Ma WJ, Sekhon P, Rai P, Menzies SC, Hoshino T, Fratzscher AS, Roth A, Madsen K, Sly LM.   +9 more
europepmc   +1 more source

Efficacy and safety of ustekinumab and vedolizumab in very early‐onset inflammatory bowel disease: A multicenter study from the pediatric inflammatory bowel disease Porto Group of ESPGHAN

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objective We aimed to assess vedolizumab and ustekinumab efficacy and safety in patients with very‐early onset inflammatory bowel disease (VEO‐IBD). Methods A retrospective study involving 29 European and North American sites affiliated with the IBD Porto Group of European Society for Paediatric Gastroenterology Hepatology and Nutrition ...
Luca Scarallo, Paolo Lionetti, Jaroslaw Kierkus, Lauren Collen, Victoria Riedl, Christian Jakobsen, Gemma Pujol‐Muncunill, Kaija‐Leena Kolho, Marta Velasco Rodriguez‐Belvis, Katarina Mitrova, Darja Urlep, Benedicte Pigneur, Seamus Hussey, Firas Rinawi, Jan De Laffolie, Karl Mårild, Anat Yerushalmy‐Feler, Raffi Lev Tzion, Maya Granot, Marina Aloi, Elisabeth De Greef, Christos Tzvinikos, Christoph Norden, Caterina Strisciuglio, Kwang Yang Lee, Rémi Duclaux‐Loras, Saverio Pochesci, Naire Sansotta, Pejman Rohani, Dror S. Shouval, Yael Weintraub, CEDATA Group, Carsten Posovszky, Philip Bufler, Andreas Krahl, Stephan Buderus, Almuthe Hauer, Michael Friedt, Stefan Trenkel, Martin Laass, Söhnke Dammann, Klaus Michael Keller, Thomas Lang, Anke Dick, Steffen Reinsch, Viola Schulze   +45 more
wiley   +1 more source

Crohn Disease [PDF]

Clinics in Colon and Rectal Surgery, 2013
openaire   +2 more sources

Raising the bar: Utilizing quality improvement tools to increase compliance with clinical care guidelines in inflammatory bowel disease patients

JPGN Reports, EarlyView.
Abstract Patients admitted for inflammatory bowel disease (IBD) are often managed by rotating teams of care providers during their hospital stay. This can lead to potential variability in the care they receive. Our team developed a scoring system of six key high‐quality care components called the standardized IBD care index (SICI) to standardize care ...
Amir Jazayeri, Emi Suzuki, Laura Bauman, Brent Polk, Jeannie S. Huang   +4 more
wiley   +1 more source

Perianal Crohn Disease in a Patient With Congenital Afibrinogenemia: A Multidisciplinary Therapeutic Management Challenge. [PDF]

Cureus
Bouziane A, Elmqaddam O, Koulali H, Zazour A, Ismaili Z, Kharrasse G.   +5 more
europepmc   +1 more source

Hair loss in pediatric inflammatory bowel disease: Clinical recognition and implications for care

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Angela Anaeme, Liza Siegel, Meryl Perlman   +2 more
wiley   +1 more source

The safe and effective use of tofacitinib and ustekinumab combination therapy in infantile onset inflammatory bowel disease

JPGN Reports, EarlyView.
Abstract Infantile‐onset inflammatory bowel disease (IOIBD) is a rare and severe subset of very‐early‐onset IBD, often associated with immune dysregulation and poor response to conventional therapies. Data regarding the use of Janus kinase inhibitors (JAKI) in this population is limited.
Smridhi Mahajan, Christian Wysocki, Bhaskar Gurram   +2 more
wiley   +1 more source

Upadacitinib for recalcitrant extraintestinal Crohn disease. [PDF]

JAAD Case Rep
Seward AH, Callen JP.
europepmc   +1 more source

Rectal stump management in paediatric ulcerative colitis—An international survey for the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition PORTO Inflammatory Bowel Disease group study

JPGN Reports, EarlyView.
Abstract Objective To evaluate current international clinical practice in the assessment and management of rectal stump disease activity following colectomy in paediatric ulcerative colitis (UC). Methods A web‐based survey comprising 18 questions was distributed to paediatric gastroenterologists via European Porto inflammatory bowel disease (IBD ...
Beth Gordon, Sarah Cooper, Billy Bourke, Séamus Hussey   +3 more
wiley   +1 more source